{"id":339511,"date":"2026-11-04T16:57:31","date_gmt":"2026-11-04T11:27:31","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/biocon-q2-results-fy27-pat-41-crore\/"},"modified":"2026-11-04T16:57:31","modified_gmt":"2026-11-04T11:27:31","slug":"biocon-q2-results-fy27-pat-41-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/biocon-q2-results-fy27-pat-41-crore\/","title":{"rendered":"Biocon Q2 Results FY27: PAT Falls 51.12% to Rs 41.30 Cr, Revenue Rs 4,388.90 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Biocon Q2 Results FY27 were declared on 4 November 2026, and the quarterly results show revenue of Rs 4,388.90 Cr against Rs 4,295.50 Cr a year earlier, a YoY growth of 2.17%. Net profit stood at Rs 41.30 Cr compared with Rs 84.50 Cr in the same quarter last year, a fall of 51.12%. Revenue moved up while profit moved down, a split the sections below examine.<\/p>\n<\/div>\n

Biocon Ltd<\/a> (BIOCON) Q2 Results FY27 announced on 4 November 2026, covering the company’s financial performance for the July to September quarter. Revenue rose to Rs 4,388.90 Cr from Rs 4,295.50 Cr, while net profit, also called PAT, fell to Rs 41.30 Cr from Rs 84.50 Cr. The results date for this filing is 4 November 2026, and Biocon Q2 Results FY27 pair a revenue gain with a profit decline.<\/p>\n

This results analysis from Univest covers the financial highlights, business drivers, outlook and risks behind Biocon Q2 Results, so the focus stays on Biocon’s own revenue and net profit. The Financial Highlights table follows next.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n